RESUMO

Malignant mesotheliomas are rare types of cancers that affect the mesothelial surfaces, usually the pleura and peritoneum. They are associated with asbestos exposure, but due to a latency period of more than 30 years and difficult diagnosis, most cases are not detected until they reach advanced stages. Treatment options for this tumor type are very limited and survival ranges from 12 to 36 months. This review discusses the molecular physiopathology, current diagnosis, and latest therapeutic options for this disease.

Assuntos

Amianto , Mesotelioma Maligno , Mesotelioma , Neoplasias Pleurais , Amianto/toxicidade , Humanos , Mesotelioma/terapia , Pleura , Neoplasias Pleurais/diagnóstico , Neoplasias Pleurais/terapia